新型隐球菌非包被变异株 I. 毒力研究及可溶性多糖的特性。
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.
机构信息
Department of Microbiology, University of Iowa, Iowa City, Iowa 52240.
出版信息
Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.
Abstract
A weakly virulent nonencapsulated variant of Cryptococcus neoformans is described. The chemical structure and antigenicity of the soluble polysaccharides produced by the variant strain and a typical virulent strain were compared. The soluble polysaccharides produced by both strains were composed of the same constituent monosaccharides; however, the virulent strain produced a polysaccharide having a greater uronic acid content and a larger molecular size than that of the variant strain. Soluble polysaccharides from the two strains are not closely related immunologically. Soluble polysaccharide obtained from the virulent strain did not affect persistence of the variant strain in mice.
摘要
现描述了一种新型隐球菌的弱毒非荚膜变异株。比较了变异株和典型毒力株所产生的可溶性多糖的化学结构和抗原性。两株菌所产生的可溶性多糖均由相同的单糖组成；然而，毒力株所产生的多糖的酸性多糖含量和分子量均大于变异株。两株菌的可溶性多糖在免疫学上没有密切的关系。从毒力株获得的可溶性多糖不会影响变异株在小鼠体内的持续存在。
相似文献
1
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.
Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.
2
Characterization of pathogenic constituents of Cryptococcus neoformans strains.
Microbiol Immunol. 1985;29(6):517-32. doi: 10.1111/j.1348-0421.1985.tb00854.x.
3
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Infect Immun. 1986 Dec;54(3):735-41. doi: 10.1128/iai.54.3.735-741.1986.
4
Immediate hypersensitivity to Cryptococcus neoformans.
Infect Immun. 1981 Feb;31(2):842-4. doi: 10.1128/iai.31.2.842-844.1981.
5
Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D.
Microbiol Immunol. 1985;29(10):981-91. doi: 10.1111/j.1348-0421.1985.tb02962.x.
6
Cryptococcus neoformans. 3. Inhibition of phagocytosis.
J Bacteriol. 1968 Jan;95(1):5-8. doi: 10.1128/jb.95.1.5-8.1968.
7
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.
Infect Immun. 1986 Dec;54(3):742-50. doi: 10.1128/iai.54.3.742-750.1986.
8
Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.
Infect Immun. 1977 Apr;16(1):99-106. doi: 10.1128/iai.16.1.99-106.1977.
9
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
Infect Immun. 1984 Mar;43(3):879-86. doi: 10.1128/iai.43.3.879-886.1984.
10
In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
Infect Immun. 1999 Jun;67(6):3096-107. doi: 10.1128/IAI.67.6.3096-3107.1999.
引用本文的文献
1
A Quick reCAP: Discovering Capsule Mutants.
J Fungi (Basel). 2024 Jan 30;10(2):114. doi: 10.3390/jof10020114.
2
Antifungal Peptide SP1 Damages Polysaccharide Capsule of Cryptococcus neoformans and Enhances Phagocytosis of Macrophages.
Microbiol Spectr. 2023 Mar 14;11(2):e0456222. doi: 10.1128/spectrum.04562-22.
3
Phenotypic Plasticity in the Productions of Virulence Factors Within and Among Serotypes in the Cryptococcus neoformans Species Complex.
Mycopathologia. 2022 Feb;187(1):65-83. doi: 10.1007/s11046-021-00597-3. Epub 2021 Oct 25.
4
Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses.
mBio. 2013 Jan 15;4(1):e00522-12. doi: 10.1128/mBio.00522-12.
5
Intracellular cryptococci suppress Fc-mediated cyclin D1 elevation.
Commun Integr Biol. 2010 Jul;3(4):390-1. doi: 10.4161/cib.3.4.12090.
6
Immune restoration diseases reflect diverse immunopathological mechanisms.
Clin Microbiol Rev. 2009 Oct;22(4):651-63. doi: 10.1128/CMR.00015-09.
7
Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule.
Mol Microbiol. 2009 Oct;74(1):126-138. doi: 10.1111/j.1365-2958.2009.06855.x. Epub 2009 Sep 2.
8
Expression of capsule-associated genes of Cryptococcus neoformans.
Mycopathologia. 2005 Aug;160(1):1-7. doi: 10.1007/s11046-005-0139-6.
9
Role of phagocytosis in the virulence of Cryptococcus neoformans.
Eukaryot Cell. 2004 Oct;3(5):1067-75. doi: 10.1128/EC.3.5.1067-1075.2004.
10
Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes.
Infect Immun. 2002 Nov;70(11):5972-81. doi: 10.1128/IAI.70.11.5972-5981.2002.
本文引用的文献
1
Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.
Infect Immun. 1970 Jun;1(6):526-31. doi: 10.1128/iai.1.6.526-531.1970.
2
The use of gastric mucin to lower resistance of laboratory animals to systemic fungus infections.
J Infect Dis. 1951 Mar-Apr;88(2):151-5. doi: 10.1093/infdis/88.2.151.
3
Isolation of a dry variant from a mucoid strain of Cryptococcus neoformas and preliminary comparative studies.
J Bacteriol. 1962 Apr;83(4):926-8. doi: 10.1128/jb.83.4.926-928.1962.
4
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
J Immunol. 1965 Jun;94:916-20.
5
NATURAL HOST RESISTANCE TO INFECTION WITH CRYPTOCOCCUS NEOFORMANS. III. THE EFFECT OF CRYPTOCOCCAL POLYSACCHARIDE UPON THE PHYSIOLOGY OF THE RETICULOENDOTHELIAL SYSTEM OF LABORATORY ANIMALS.
J Infect Dis. 1964 Feb;114:95-106. doi: 10.1093/infdis/114.1.95.
6
Taxonomy of Cryptococcus neoformans and its variety uniguttulatus.
Antonie Van Leeuwenhoek. 1961;27:59-64. doi: 10.1007/BF02538423.
7
Studies of proteins and antibodies by specific hemagglutination and hemolysis of proteinconjugated erythrocytes.
Int Arch Allergy Appl Immunol. 1958;13(1-2):1-38. doi: 10.1159/000228473.
8
The genus Cryptococcus.
Bacteriol Rev. 1956 Sep;20(3):189-201. doi: 10.1128/br.20.3.189-201.1956.
9
The antigenic compostion of Cryptococcus neoformans. IV. The use of paper chromatography for following purification of the capsular polysaccharide.
J Bacteriol. 1953 May;65(5):571-7. doi: 10.1128/jb.65.5.571-577.1953.
10
Cryptococcosis due to an unusually slow-growing organism.
Am J Med Technol. 1967 Sep-Oct;33(5):397-9.
Zotero 插件